Singapore, March 7 -- Identifying therapeutic gene targets is essential for advancing personalised medicine and addressing the genetic basis of diseases. However, traditional experimental methods for ... Read More
Singapore, March 7 -- US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its Decoy platform. These patents cover the use of Decoy bacteri... Read More
Singapore, March 7 -- South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has announced a second agreement wi... Read More
Singapore, March 6 -- Pantai Hospital Kuala Lumpur (PHKL) and IMU University have officially entered into a five-year Memorandum of Understanding (MoU) to foster collaboration in biomedical science re... Read More
Singapore, March 6 -- China's oncology firm Antengene Corporation has announced that the Indonesia National Agency of Drug and Food Control (BPOM) has approved a New Drug Application (NDA) for XPOVIO ... Read More
Singapore, March 6 -- Taiwan-based Health2Sync, a leading digital health company specialising in chronic disease management, has raised over $20 million in a Series C funding round and earlier extensi... Read More
Singapore, March 6 -- Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement to establish a joint venture for the development of a cell therapy pr... Read More
Singapore, March 6 -- SK Chemicals, which developed Korea's first herbal medicine product for osteoarthritis, Joins, has expanded its pain management portfolio. The company has signed a distribution a... Read More
Singapore, March 6 -- Taiwan-based Health2Sync, a leading digital health company specialising in chronic disease management, has raised over $20 million in a Series C funding round and earlier extensi... Read More
Singapore, March 6 -- China's oncology firm Antengene Corporation has announced that the Indonesia National Agency of Drug and Food Control (BPOM) has approved a New Drug Application (NDA) for XPOVIO(... Read More